Found: 25
Select item for more details and to access through your institution.
Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.
- Published in:
- BMC Complementary Medicine & Therapies, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12906-020-2849-1
- By:
- Publication type:
- Article
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ALPHA-SYNUCLEIN SPECIES AS POTENTIAL CSF BIOMARKERS FOR DEMENTIA WITH LEWY BODIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P338, doi. 10.1016/j.jalz.2017.06.063
- By:
- Publication type:
- Article
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease.
- Published in:
- Scientific Reports, 2017, p. 40263, doi. 10.1038/srep40263
- By:
- Publication type:
- Article
RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 6, p. 820, doi. 10.3390/biom11060820
- By:
- Publication type:
- Article
Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system.
- Published in:
- Frontiers in Physiology, 2023, p. 1, doi. 10.3389/fphys.2023.1203723
- By:
- Publication type:
- Article
Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0241773
- By:
- Publication type:
- Article
Novel engineered nanobodies specific for N‐terminal region of alpha‐synuclein recognize Lewy‐body pathology and inhibit in‐vitro seeded aggregation and toxicity.
- Published in:
- FEBS Journal, 2022, v. 289, n. 15, p. 4657, doi. 10.1111/febs.16376
- By:
- Publication type:
- Article
Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65035-8
- By:
- Publication type:
- Article
Heterogeneity in α‐synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
- Published in:
- Neuropathology & Applied Neurobiology, 2019, v. 45, n. 6, p. 597, doi. 10.1111/nan.12531
- By:
- Publication type:
- Article
Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 5, p. 786, doi. 10.3390/v13050786
- By:
- Publication type:
- Article
Investigating the presence of doubly phosphorylated α‐synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.
- Published in:
- Brain Pathology, 2020, v. 30, n. 4, p. 831, doi. 10.1111/bpa.12845
- By:
- Publication type:
- Article
Antibodies against alpha‐synuclein: tools and therapies.
- Published in:
- Journal of Neurochemistry, 2019, v. 150, n. 5, p. 612, doi. 10.1111/jnc.14713
- By:
- Publication type:
- Article
Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
- Published in:
- 2018
- By:
- Publication type:
- corrected article
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rotenone and elevated extracellular potassium concentration induce cell-specific fibrillation of α-synuclein in axons of cholinergic enteric neurons in the guinea-pig ileum.
- Published in:
- Neurogastroenterology & Motility, 2017, v. 29, n. 4, p. n/a, doi. 10.1111/nmo.12985
- By:
- Publication type:
- Article
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
- Published in:
- Molecular Neurodegeneration, 2016, v. 11, p. 1, doi. 10.1186/s13024-016-0072-9
- By:
- Publication type:
- Article
Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity.
- Published in:
- Molecules, 2021, v. 26, n. 12, p. 3736, doi. 10.3390/molecules26123736
- By:
- Publication type:
- Article
Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32588-8
- By:
- Publication type:
- Article
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers.
- Published in:
- Translational Neurodegeneration, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40035-020-00192-4
- By:
- Publication type:
- Article
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy.
- Published in:
- Translational Neurodegeneration, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40035-019-0159-7
- By:
- Publication type:
- Article
Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer's Disease.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11326, doi. 10.3390/ijms241411326
- By:
- Publication type:
- Article
α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Structural insights into the unique recognition module between α‐synuclein peptide and nanobody.
- Published in:
- Protein Science: A Publication of the Protein Society, 2024, v. 33, n. 2, p. 1, doi. 10.1002/pro.4875
- By:
- Publication type:
- Article